Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040115 · ClinicalTrials.gov registry record
Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 104
- Enrollment target
NCT03040115: Completed study, sponsored by University of Cincinnati.
NCT03040115 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03040115 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with Birt-Hogg-Dube syndrome (BHD). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the BHD foundation website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 100 patients with BHD for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.
Primary Outcome
The investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with Birt-Hogg-Dube syndrome. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-08 |
What the finished NCT03040115 record still lists
NCT03040115 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT03040115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03040115 about?
NCT03040115 is a clinical study titled "Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome". The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with Birt-Hogg-Dube syndrome (BHD). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the BHD foundation website. Patients will have access...
What is the current status of trial NCT03040115?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2015-08. Estimated completion is 2019-08.
What interventions are being tested in trial NCT03040115?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT03040115?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia